Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Current Assets: 2011-2018

Historic Current Assets for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Jun 2018 value amounting to $39.9 million.

  • EyePoint Pharmaceuticals' Current Assets rose 173.67% to $48.4 million in Q1 2019 from the same period last year, while for Mar 2019 it was $48.4 million, marking a year-over-year increase of 173.67%. This contributed to the annual value of $39.9 million for FY2018, which is 124.97% up from last year.
  • As of FY2018, EyePoint Pharmaceuticals' Current Assets stood at $39.9 million, which was up 124.97% from $17.7 million recorded in FY2017.
  • EyePoint Pharmaceuticals' 5-year Current Assets high stood at $39.9 million for FY2018, and its period low was $17.7 million during FY2017.
  • For the 3-year period, EyePoint Pharmaceuticals' Current Assets averaged around $29.2 million, with its median value being $30.0 million (2016).
  • As far as peak fluctuations go, EyePoint Pharmaceuticals' Current Assets slumped by 40.79% in 2017, and later spiked by 124.97% in 2018.
  • Over the past 5 years, EyePoint Pharmaceuticals' Current Assets (Yearly) stood at $19.3 million in 2014, then skyrocketed by 54.27% to $29.8 million in 2015, then grew by 0.42% to $30.0 million in 2016, then tumbled by 40.79% to $17.7 million in 2017, then soared by 124.97% to $39.9 million in 2018.